Private Capital Group’s Novartis NVS Stock Holding History

Private Capital Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$136K	Sell	1,604 -221	-12%	-$19.4K	0.1%	197
2022 Q1	$160K	Sell	1,825 -121	-6%	-$10.5K	0.04%	271
2021 Q4	$170K	Sell	1,946 -517	-21%	-$42.9K	0.04%	274
2021 Q3	$201K	Buy	2,463 +7	+0.3%	+$630	0.05%	236
2021 Q2	$224K	Buy	2,456 +399	+19%	+$35.5K	0.05%	216
2021 Q1	$176K	Sell	2,057 -2,153	-51%	-$193K	0.04%	242
2020 Q4	$398K	Sell	4,210 -51	-1%	-$4.46K	0.07%	186
2020 Q3	$371K	Sell	4,261 -464	-10%	-$40.2K	0.08%	172
2020 Q2	$413K	Sell	4,725 -132	-3%	-$11.4K	0.09%	161
2020 Q1	$400K	Buy	4,857 +708	+17%	+$63.2K	0.1%	139
2019 Q4	$392K	Buy	4,149 +397	+11%	+$35.6K	0.08%	150
2019 Q3	$326K	Buy	3,752 +1,752	+88%	+$157K	0.06%	191
2019 Q2	$151K	Sell	2,000 -2,179	-52%	-$184K	0.03%	276
2019 Q1	$360K	Buy	4,179 +1,099	+36%	+$88.2K	0.07%	178
2018 Q4	$237K	Buy	3,080 +255	+9%	+$19.8K	0.05%	207
2018 Q3	$218K	Buy	2,825 +113	+4%	+$8.35K	0.04%	240
2018 Q2	$183K	Sell	2,712 -41	-1%	-$2.83K	0.04%	262
2018 Q1	$204K	Buy	2,753 +2,751	+137,550%	+$209K	0.05%	237
2017 Q4	$160K	Buy	+2	New	+$151	0.04%	275

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Private Capital Group's NVS Position: Q2 2022 in Review

Private Capital Group reduced its Novartis (NVS) stake by 12% in Q2 2022, selling an estimated $19.4K and leaving 1,604 shares worth $136K. The position accounts for 0.1% of the portfolio, ranked #197.

Private Capital Group first reported a position in NVS in Q4 2017 and has held it in 19 quarters since. The position peaked at $413K in Q2 2020. 1,141 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

Private Capital Group held 1,604 shares of Novartis worth $136K as of Q2 2022.
Private Capital Group sold 221 Novartis shares in Q2 2022, an estimated $19.4K.
Novartis made up 0.1% of Private Capital Group's portfolio in Q2 2022, its #197 holding.
Private Capital Group first reported a position in Novartis in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Novartis position peaked at $413K in Q2 2020.
1,141 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.